Cargando…
Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer
Although anti–programmed death‐1 (PD‐1)/programmed death ligand 1 (PD‐L1) immunotherapy has achieved great success in some cancers, most colorectal cancer (CRC) patients remain unresponsive. Therefore, further clarification of the underlying mechanisms is needed to improve the therapy. In this study...
Autores principales: | Wang, Chaoyan, Weng, Menghan, Xia, Shuli, Zhang, Min, Chen, Chaoyi, Tang, Jinlong, Huang, Dan, Yu, Hongfei, Sun, Wenjie, Zhang, Honghe, Lai, Maode |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780007/ https://www.ncbi.nlm.nih.gov/pubmed/33058325 http://dx.doi.org/10.1111/cas.14690 |
Ejemplares similares
-
Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma
por: Song, Huijuan, et al.
Publicado: (2020) -
Alternative splicing in mesenchymal stem cell differentiation
por: Park, Jung Woo, et al.
Publicado: (2020) -
M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands
por: Hason, Martina, et al.
Publicado: (2022) -
MicroRNA124 and microRNA21-5p regulate migration, proliferation and differentiation of rat bone marrow mesenchymal stem cells
por: Liu, Yan, et al.
Publicado: (2020) -
MERISTEM-DEFECTIVE regulates the balance between stemness and differentiation in the root meristem through RNA splicing control
por: Thompson, Helen L., et al.
Publicado: (2023)